DBL-1 (Dpp and BMP-Like 1) is the C. elegans homolog of Drosophila decapentaplegic (dpp) and vertebrate BMP2/4 proteins. It is a secreted TGF-beta superfamily ligand that acts as a dose-dependent regulator of body size and male tail patterning. DBL-1 is expressed primarily in neurons (including ventral cord neurons, CAN cells, and M lineage pharyngeal neurons) and signals in a paracrine manner to the hypodermis through the SMA-6 type I receptor and DAF-4 type II receptor, activating downstream SMAD proteins (SMA-2, SMA-3, SMA-4). Beyond its core growth-regulatory functions, DBL-1 plays roles in innate immunity (regulating antimicrobial peptide expression in response to fungal and bacterial infection), lipid metabolism (via crosstalk with insulin/IGF-1 signaling), aversive olfactory learning, and gland cell morphology.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005125
cytokine activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: DBL-1 functions as a secreted signaling molecule similar to cytokines, activating receptor-mediated signaling cascades. As a TGF-beta/BMP superfamily member, it acts as a paracrine signal from neurons to hypodermal cells. The IBA annotation is phylogenetically sound given DBL-1's membership in the TGF-beta superfamily.
Reason: DBL-1 is a secreted signaling ligand that activates receptor-mediated pathways, consistent with cytokine activity. The IBA annotation correctly captures this molecular function based on phylogenetic inference from BMP family members.
Supporting Evidence:
PMID:9847238
DBL-1 acts as a dose-dependent regulator of these processes
file:worm/dbl-1/dbl-1-deep-research-falcon.md
model: Edison Scientific Literature
|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: DBL-1 is a secreted protein that signals from neurons to hypodermal cells in a paracrine manner. As a TGF-beta/BMP family member, it is processed and secreted to act on target cells expressing cognate receptors.
Reason: DBL-1 is established as a secreted ligand that acts non-cell-autonomously. UniProt annotation indicates "Secreted" subcellular location. The protein signals from neurons to the hypodermis, requiring extracellular localization for its function.
Supporting Evidence:
PMID:12397107
As dbl-1 is expressed primarily in the nervous system, these results suggest a model in which postembryonic growth of hypodermal cells is regulated by TGFbeta-related signaling from the nervous system to the hypodermis
|
|
GO:0030509
BMP signaling pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: DBL-1 is the ligand of the C. elegans BMP-like (Sma/Mab) signaling pathway. This is a core function of the protein, established through extensive genetic and biochemical studies.
Reason: DBL-1 is the founding member of the C. elegans BMP pathway. PMID:9847238 identified it as a BMP homolog, and subsequent studies confirmed it signals through SMA-6 receptor and SMAD proteins. This is the central molecular function of DBL-1.
Supporting Evidence:
PMID:9847238
We cloned the dbl-1 gene, a C. elegans homolog of Drosophila decapentaplegic and vertebrate BMP genes
PMID:12717735
In the nematode Caenorhabditis elegans, a TGFbeta-related signaling pathway regulates body size and male tail morphogenesis
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation based on InterPro domain and UniProt subcellular location. DBL-1 is a secreted protein, so this annotation is correct but less specific than GO:0005615 (extracellular space) which is also annotated.
Reason: As a secreted TGF-beta ligand, DBL-1 is correctly annotated to extracellular region. This is a broader term than extracellular space but accurately reflects the protein's localization after secretion.
Supporting Evidence:
PMID:9847238
A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans
|
|
GO:0008083
growth factor activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: DBL-1 acts as a dose-dependent regulator of body size, functioning as a growth factor. Loss-of-function causes reduced body size while overexpression causes increased body size.
Reason: DBL-1 functions as a classical growth factor - it is a secreted signaling molecule that regulates cell and organism size in a dose-dependent manner. PMID:9847238 demonstrates both loss-of-function (small) and gain-of-function (large) body size phenotypes.
Supporting Evidence:
PMID:9847238
Loss-of-function mutations in dbl-1 cause markedly reduced body size and defective male copulatory structures
|
|
GO:0010628
positive regulation of gene expression
|
IMP
PMID:18158917 Regulation of rnt-1 expression mediated by the opposing effe... |
ACCEPT |
Summary: PMID:18158917 shows DBL-1 is required for counteracting BRO-1-mediated repression of rnt-1 expression at postembryonic stages, and ectopic DBL-1 expression induces rnt-1 transcription.
Reason: The publication demonstrates DBL-1 positively regulates rnt-1 gene expression, opposing the repressive activity of BRO-1. This is a well-characterized regulatory relationship where DBL-1/TGF-beta signaling activates downstream gene expression.
Supporting Evidence:
PMID:18158917
we found that the TGFbeta homolog, DBL-1, was required for counteracting the repressive activity of BRO-1 at postembryonic stages
|
|
GO:0019216
regulation of lipid metabolic process
|
IMP
PMID:29162682 Caenorhabditis elegans DBL-1/BMP Regulates Lipid Accumulatio... |
ACCEPT |
Summary: PMID:29162682 demonstrates DBL-1 regulates lipid accumulation in C. elegans. Both loss and gain of DBL-1 function result in reduced lipid stores. DBL-1 acts upstream of insulin/IGF-1 signaling in lipid metabolism.
Reason: This is a well-established secondary function of DBL-1. The study shows dbl-1 mutants have reduction in neutral lipids, and demonstrates epistatic relationship with DAF-2/insulin signaling for lipid regulation.
Supporting Evidence:
PMID:29162682
Similarly, we observed a decrease in dbl-1 mutants by ∼35% compared to wild type
PMID:29162682
genetic evidence indicates that DBL-1/BMP functions upstream of Insulin/IGF-1 Signaling in lipid metabolism
|
|
GO:0022604
regulation of cell morphogenesis
|
IMP
PMID:24690231 CEH-28 activates dbl-1 expression and TGF-β signaling in the... |
ACCEPT |
Summary: PMID:24690231 shows dbl-1 mutants exhibit morphological defects in g1 gland cells located adjacent to M4 neuron in the pharynx, and these defects can be partially rescued by M4-specific expression of dbl-1.
Reason: The study demonstrates DBL-1 is required for proper gland cell morphology via an R-Smad-independent TGF-beta signaling mechanism. This represents a distinct morphogenetic function of DBL-1.
Supporting Evidence:
PMID:24690231
both ceh-28 and dbl-1 mutants exhibit morphological defects in the g1 gland cells located adjacent to M4 in the pharynx, and these defects can be partially rescued by M4-specific expression of dbl-1 in these mutants
|
|
GO:0045944
positive regulation of transcription by RNA polymerase II
|
IMP
PMID:19198592 Neuroimmune regulation of antimicrobial peptide expression b... |
ACCEPT |
Summary: PMID:19198592 demonstrates neuronal expression of DBL-1 promotes transcription of antimicrobial peptide genes (cnc-2 caenacin) in the epidermis in a dose-dependent paracrine manner.
Reason: The study shows DBL-1 activates transcription of antimicrobial peptide genes in the epidermis. As TGF-beta signaling ultimately activates SMAD-mediated transcription, this annotation accurately reflects DBL-1's role in promoting gene expression.
Supporting Evidence:
PMID:19198592
neuronal expression of the transforming growth factor-beta homolog DBL-1 promoted cnc-2 expression in the epidermis in a dose-dependent paracrine way
|
|
GO:0030511
positive regulation of transforming growth factor beta receptor signaling pathway
|
IGI
PMID:28068334 Two Paralogous Tetraspanins TSP-12 and TSP-14 Function with ... |
MODIFY |
Summary: PMID:28068334 demonstrates tetraspanins TSP-12 and TSP-14 promote BMP signaling through ADAM10/SUP-17, with genetic interactions involving dbl-1 pathway components. The IGI evidence reflects genetic interactions showing positive regulation of TGF-beta signaling.
Reason: While the annotation captures DBL-1's role in promoting BMP signaling, DBL-1 itself IS the TGF-beta pathway ligand rather than a regulator of the pathway. The more accurate annotation would be "BMP signaling pathway" (GO:0030509) which is already annotated. This annotation is somewhat circular - DBL-1 doesn't regulate TGF-beta signaling, it IS the signal.
Proposed replacements:
BMP signaling pathway
Supporting Evidence:
PMID:28068334
Here, we show that TSP-12 and TSP-14 function redundantly in BMP signaling by regulating the cell surface localization of the ADAM10
|
|
GO:0042661
regulation of mesodermal cell fate specification
|
IGI
PMID:25978409 Promotion of bone morphogenetic protein signaling by tetrasp... |
KEEP AS NON CORE |
Summary: PMID:25978409 describes the role of the Sma/Mab pathway (including DBL-1) in regulating the postembryonic M lineage mesoderm development. Mutations in Sma/Mab pathway components suppress sma-9 M lineage defects.
Reason: While the Sma/Mab pathway involving DBL-1 does affect M lineage patterning, this is demonstrated primarily through suppression of sma-9 mutant phenotypes rather than direct regulation. The core function of DBL-1 is body size regulation and male tail patterning; M lineage effects are more peripheral.
Supporting Evidence:
PMID:25978409
We have shown that mutations in the core components of the Sma/Mab pathway (Fig 2A) do not cause any M lineage defect on their own, but they suppress the dorsoventral patterning defects of sma-9 mutants
|
|
GO:0010468
regulation of gene expression
|
IMP
PMID:17526726 Specificity and complexity of the Caenorhabditis elegans inn... |
ACCEPT |
Summary: PMID:17526726 shows DBL-1 pathway regulates expression of distinct but overlapping sets of antimicrobial genes as part of the C. elegans innate immune response.
Reason: DBL-1/TGF-beta signaling regulates gene expression as part of its mechanism of action. The study demonstrates immune pathway signaling by DBL-1 affects antimicrobial gene expression patterns.
Supporting Evidence:
PMID:17526726
we found that different immune response pathways regulate expression of distinct but overlapping sets of antimicrobial genes
|
|
GO:0050832
defense response to fungus
|
IMP
PMID:19198592 Neuroimmune regulation of antimicrobial peptide expression b... |
ACCEPT |
Summary: PMID:19198592 demonstrates DBL-1 promotes antifungal defense by activating expression of caenacin antimicrobial peptides in the epidermis in response to Drechmeria coniospora fungal infection.
Reason: This is a well-characterized immune function of DBL-1. The study shows neuronal DBL-1 activates epidermal antimicrobial peptide expression during fungal infection via a non-canonical TGF-beta pathway.
Supporting Evidence:
PMID:19198592
After being infected by the fungus Drechmeria coniospora, Caenorhabditis elegans produces antimicrobial peptides in its epidermis
PMID:19198592
The caenacin (cnc) genes enhanced survival after fungal infection
|
|
GO:0050829
defense response to Gram-negative bacterium
|
IMP
PMID:17975555 A conserved Toll-like receptor is required for Caenorhabditi... |
ACCEPT |
Summary: PMID:17975555 demonstrates the role of TOL-1 and associated pathways including DBL-1 in defense against Salmonella enterica (Gram-negative bacterium) infection.
Reason: DBL-1 contributes to innate immune defense against bacterial pathogens. UniProt annotation indicates "Plays a protective role in response to infection by the Gram-negative bacterium S.marcescens, by activating expression of genes involved in innate immunity."
Supporting Evidence:
PMID:17975555
tol-1(nr2033) mutants are killed by the human pathogen Salmonella enterica
|
|
GO:0050830
defense response to Gram-positive bacterium
|
IMP
PMID:17975555 A conserved Toll-like receptor is required for Caenorhabditi... |
ACCEPT |
Summary: The annotation suggests DBL-1 is involved in defense against Gram-positive bacteria based on PMID:17975555, though the paper primarily focuses on Gram-negative Salmonella.
Reason: DBL-1 is part of the C. elegans innate immune response system. UniProt annotation indicates involvement in antibacterial defense. The broader innate immune role of DBL-1 signaling encompasses responses to both Gram-negative and Gram-positive bacteria.
Supporting Evidence:
PMID:17975555
The results indicate that TOL-1 has a direct role in defence response to certain Gram-negative bacteria
|
|
GO:0005615
extracellular space
|
ISS
PMID:9847238 A BMP homolog acts as a dose-dependent regulator of body siz... |
ACCEPT |
Summary: ISS annotation based on similarity to BMP proteins which are secreted ligands. PMID:9847238 identified DBL-1 as a BMP homolog. Duplicate of the IBA annotation.
Reason: This annotation is correct based on homology to secreted BMP ligands. DBL-1 signals from neurons to target cells, requiring extracellular localization. Keeping both ISS and IBA provides independent evidence support.
Supporting Evidence:
PMID:9847238
a C. elegans homolog of Drosophila decapentaplegic and vertebrate BMP genes
|
|
GO:0030509
BMP signaling pathway
|
ISS
PMID:9847238 A BMP homolog acts as a dose-dependent regulator of body siz... |
ACCEPT |
Summary: ISS annotation based on sequence similarity to BMP ligands. PMID:9847238 established DBL-1 as a BMP homolog. Duplicate of IBA annotation.
Reason: DBL-1 is the ligand of the C. elegans BMP (Sma/Mab) pathway. This is the core function of the protein, supported by both phylogenetic (IBA) and sequence similarity (ISS) evidence.
Supporting Evidence:
PMID:9847238
Evidence from genetic interactions indicates that these effects are mediated by a Smad signaling pathway, for which DBL-1 is a previously unidentified ligand
|
|
GO:0070700
BMP receptor binding
|
ISS
PMID:9847238 A BMP homolog acts as a dose-dependent regulator of body siz... |
ACCEPT |
Summary: ISS annotation based on homology to BMP ligands that bind BMP receptors. DBL-1 signals through the SMA-6 type I receptor and DAF-4 type II receptor.
Reason: As a BMP ligand, DBL-1 must bind to its cognate receptors (SMA-6 and DAF-4) to transduce signals. This molecular function is correctly inferred from homology to vertebrate BMPs that bind BMP receptors.
Supporting Evidence:
PMID:9847238
Evidence from genetic interactions indicates that these effects are mediated by a Smad signaling pathway
PMID:11784045
One of these pathways regulates body length and is composed of the ligand DBL-1, serine/threonine protein kinase receptors SMA-6 and DAF-4
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IMP
PMID:12571101 Cyclic GMP-dependent protein kinase EGL-4 controls body size... |
ACCEPT |
Summary: PMID:12571101 shows EGL-4/cGMP-dependent protein kinase represses body size through DBL-1/TGF-beta pathway. Genetic analysis places DBL-1 as a positive regulator of body growth.
Reason: DBL-1 positively regulates body size - loss-of-function causes small body size and overexpression causes large body size. This is the primary phenotypic function of DBL-1.
Supporting Evidence:
PMID:12571101
Experiments on genetic interaction suggest that the cGMP-EGL-4 signaling pathway represses body size and lifespan through DBL-1/TGF-beta and insulin pathways, respectively
|
|
GO:0045087
innate immune response
|
IMP
PMID:19198592 Neuroimmune regulation of antimicrobial peptide expression b... |
ACCEPT |
Summary: PMID:19198592 demonstrates DBL-1 functions in neuroimmune regulation, activating antimicrobial peptide expression in epidermis during pathogen infection.
Reason: DBL-1 contributes to innate immunity by activating antimicrobial peptide genes via a noncanonical TGF-beta signaling pathway. This is a well-established secondary function of DBL-1.
Supporting Evidence:
PMID:19198592
antifungal defenses are coordinately regulated by a cell-autonomous p38 cascade and a distinct cytokine-like transforming growth factor-beta signal from the nervous system
|
|
GO:0032877
positive regulation of DNA endoreduplication
|
IMP
PMID:12019225 Increased or decreased levels of Caenorhabditis elegans lon-... |
ACCEPT |
Summary: PMID:12019225 shows dbl-1 loss-of-function causes decreased hypodermal nuclear ploidy (endoreduplication) in hyp7 syncytial cells, indicating DBL-1 positively regulates this process.
Reason: The study demonstrates that dbl-1 mutants have reduced ploidy in hypodermal nuclei, indicating DBL-1 promotes endoreduplication. This contributes to the body size phenotype.
Supporting Evidence:
PMID:12019225
loss-of-function mutations in dbl-1 and lon-1, respectively, cause a decrease or increase in the ploidy of nuclei in the hypodermal syncytial cell, hyp7
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IGI
PMID:12051826 lon-1 regulates Caenorhabditis elegans body size downstream ... |
ACCEPT |
Summary: PMID:12051826 demonstrates lon-1 is a downstream target of DBL-1 signaling that regulates body size. Genetic analysis shows lon-1 acts downstream of dbl-1 in the Sma/Mab pathway.
Reason: Genetic interactions between dbl-1 and lon-1 confirm DBL-1's role in body size regulation. lon-1 mRNA is up-regulated when dbl-1 signaling is reduced, showing negative regulation by the pathway.
Supporting Evidence:
PMID:12051826
lon-1 regulates body size morphogenesis
PMID:12051826
lon-1 lies downstream of the Sma/Mab signaling cascade
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IGI
PMID:17240342 Glypican LON-2 is a conserved negative regulator of BMP-like... |
ACCEPT |
Summary: PMID:17240342 shows LON-2 glypican negatively regulates BMP-like signaling by potentially binding to DBL-1 and attenuating ligand-receptor interactions.
Reason: Genetic analysis places lon-2 upstream of dbl-1 as a negative regulator. The interaction between LON-2 and DBL-1 confirms DBL-1's role in promoting growth.
Supporting Evidence:
PMID:17240342
LON-2 negatively regulates a BMP-like signaling pathway that controls body length in C. elegans
PMID:17240342
lon-2 acts genetically upstream of the BMP-like gene dbl-1
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IMP
PMID:12397107 The expression of TGFbeta signal transducers in the hypoderm... |
ACCEPT |
Summary: PMID:12397107 demonstrates dbl-1 loss-of-function causes reduced body size due to decreased postembryonic growth, with hypodermal blast cell size most affected.
Reason: This study provides detailed characterization of body size regulation by DBL-1, showing the signaling pathway acts in hypodermis to regulate growth.
Supporting Evidence:
PMID:12397107
Loss of function of the signaling ligand (dbl-1), receptors (daf-4 and sma-6) or Smads (sma-2, sma-3 and sma-4) results in viable, but smaller animals because of a reduction in postembryonic growth
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IMP
PMID:12717735 Genetic screen for small body size mutants in C. elegans rev... |
ACCEPT |
Summary: PMID:12717735 identifies dbl-1 mutations in a genetic screen for small body size mutants, confirming its role in growth regulation.
Reason: Forward genetic screen confirms dbl-1 as a key regulator of body size within the TGF-beta pathway.
Supporting Evidence:
PMID:12717735
Among 34 Small mutants, many mutations disrupt genes encoding recognizable components of the TGFbeta pathway: DBL-1 ligand
|
|
GO:0045138
nematode male tail tip morphogenesis
|
IMP
PMID:12717735 Genetic screen for small body size mutants in C. elegans rev... |
ACCEPT |
Summary: PMID:12717735 shows dbl-1 mutants have male tail morphogenesis defects including ray fusions and abnormal spicules.
Reason: Male tail patterning is a core function of DBL-1, affecting sensory ray formation and mating structures. This is one of the two primary phenotypes (along with body size) of the Sma/Mab pathway.
Supporting Evidence:
PMID:9847238
Loss-of-function mutations in dbl-1 cause markedly reduced body size and defective male copulatory structures
PMID:12717735
Four of these 11 genes, sma-9, sma-14, sma-16, and sma-20 affect male tail morphogenesis as well as body size
|
|
GO:0002119
nematode larval development
|
IMP
PMID:12397107 The expression of TGFbeta signal transducers in the hypoderm... |
KEEP AS NON CORE |
Summary: PMID:12397107 shows dbl-1 mutants have reduced postembryonic growth affecting larval development stages.
Reason: While dbl-1 affects larval development through its role in body size regulation, this is a broad developmental term. The core function is specifically body size and male tail regulation rather than general larval development.
Supporting Evidence:
PMID:12397107
viable, but smaller animals because of a reduction in postembryonic growth
|
|
GO:0045793
positive regulation of cell size
|
IMP
PMID:12397107 The expression of TGFbeta signal transducers in the hypoderm... |
ACCEPT |
Summary: PMID:12397107 shows DBL-1 pathway affects cell size rather than cell number, with hypodermal blast cell size proportional to body size.
Reason: DBL-1 regulates body size by affecting cell size rather than cell number. This is a well-characterized mechanism of DBL-1 action.
Supporting Evidence:
PMID:12397107
different tissues are reduced in size by different proportions, with hypodermal blast cell size most closely proportional to body size
|
|
GO:0046622
positive regulation of organ growth
|
IMP
PMID:12397107 The expression of TGFbeta signal transducers in the hypoderm... |
ACCEPT |
Summary: PMID:12397107 demonstrates tissue-specific effects of DBL-1 on organ size, particularly hypodermis which is the primary target tissue.
Reason: DBL-1 regulates organ size as part of its body size regulatory function. Different organs are affected to different degrees by dbl-1 mutations.
Supporting Evidence:
PMID:12397107
different tissues are reduced in size by different proportions
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IGI
PMID:15840165 C. elegans serine-threonine kinase KIN-29 modulates TGFbeta ... |
ACCEPT |
Summary: PMID:15840165 shows KIN-29 modulates TGF-beta signaling with genetic interactions demonstrating it acts downstream of dbl-1 but upstream of lon-1 target gene.
Reason: Genetic epistasis analysis confirms dbl-1's position in the growth regulatory pathway. KIN-29 can suppress dbl-1 overexpression phenotype.
Supporting Evidence:
PMID:15840165
kin-29 is able to suppress the long mutant phenotype generated by animals over-expressing the ligand dbl-1
PMID:15840165
These data suggest that kin-29 genetically interacts with Sma/Mab pathway signaling downstream of dbl-1 but upstream of lon-1
|
|
GO:0040018
positive regulation of multicellular organism growth
|
IMP
PMID:11784045 Hypodermal expression of Caenorhabditis elegans TGF-beta typ... |
ACCEPT |
Summary: PMID:11784045 demonstrates hypodermal expression of the DBL-1 receptor SMA-6 is essential for body length, confirming DBL-1's role in growth regulation.
Reason: This study establishes the tissue-specific requirements for DBL-1 signaling in body size regulation, confirming DBL-1 as a growth-promoting signal.
Supporting Evidence:
PMID:11784045
One of these pathways regulates body length and is composed of the ligand DBL-1, serine/threonine protein kinase receptors SMA-6 and DAF-4
|
Q: How does DBL-1 coordinate body size regulation with lipid metabolism?
Q: What is the mechanism by which DBL-1 signals through both Smad-dependent and Smad-independent pathways?
Q: How is DBL-1 activity regulated at the level of ligand processing and secretion?
Experiment: Quantitative analysis of DBL-1 protein levels in different developmental stages
Experiment: Identification of direct transcriptional targets of the DBL-1/SMAD pathway
Experiment: Analysis of DBL-1 processing and secretion mechanisms
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-29T11:25:23.512129'
end_time: '2025-12-29T11:30:14.327763'
duration_seconds: 290.82
template_file: templates/gene_research_go_focused.md
template_variables:
organism: worm
gene_id: dbl-1
gene_symbol: dbl-1
uniprot_accession: G5EEL5
protein_description: 'RecName: Full=Protein dbl-1 {ECO:0000305}; AltName: Full=Dpp
and BMP-like protein 1 {ECO:0000303|PubMed:9847238}; Flags: Precursor;'
gene_info: Name=dbl-1 {ECO:0000312|WormBase:T25F10.2}; Synonyms=cet-1 {ECO:0000303|PubMed:10021351};
ORFNames=T25F10.2 {ECO:0000312|WormBase:T25F10.2};
organism_full: Caenorhabditis elegans.
protein_family: Belongs to the TGF-beta family.
protein_domains: Cystine-knot_cytokine. (IPR029034); TGF-b_C. (IPR001839); TGF-beta-rel.
(IPR015615); TGFb_CS. (IPR017948); TGF_beta (PF00019)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 21
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'dbl-1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene dbl-1 (gene ID: dbl-1, UniProt: G5EEL5) in worm.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'dbl-1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene dbl-1 (gene ID: dbl-1, UniProt: G5EEL5) in worm.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research report: dbl-1 (DBL-1) in Caenorhabditis elegans (UniProt G5EEL5)
Executive verification of identity
- Gene/protein match: dbl-1 encodes DBL-1, a Dpp/BMP2/4-like ligand of the TGF-β superfamily in C. elegans. Canonical signaling proceeds through the type II receptor DAF-4 and type I receptor SMA-6, activating R-Smads SMA-2/SMA-3 and the Co-Smad SMA-4, consistent with a cystine-knot BMP family ligand. The organism and pathway membership align with the UniProt context and WormBook/Frontiers reviews (https://doi.org/10.1895/wormbook.1.22.2, Jul 2013; https://doi.org/10.3389/fgene.2023.1220068, Sep 2023) (gumienny2013tgfβsignalingin pages 3-5, gumienny2013tgfβsignalingin pages 8-10, gumienny2013tgfβsignalingin pages 7-8, yamamoto2023tgfβpathwaysin pages 3-4).
1) Key concepts and definitions
- Core pathway: DBL-1 is a secreted BMP-like ligand that binds a heterotetramer of DAF-4 (type II) and SMA-6 (type I) serine/threonine kinase receptors. Type II phosphorylates the type I GS domain, which in turn phosphorylates R-Smads (SMA-2, SMA-3). R-Smad/Co-Smad (SMA-4) complexes accumulate in nuclei to regulate transcription. Schnurri SMA-9 is a nuclear partner that imparts specificity to Sma/Mab outputs (https://doi.org/10.1895/wormbook.1.22.2, Jul 2013) (gumienny2013tgfβsignalingin pages 3-5, gumienny2013tgfβsignalingin pages 8-10, gumienny2013tgfβsignalingin pages 7-8).
- Expression and localization: dbl-1 is expressed in cholinergic neurons in head and ventral/dorsal nerve cords; the signal is secreted to act in peripheral tissues. Receptors and Smads are expressed prominently in the hypodermis (epidermis), pharynx, and intestine, consistent with hypodermal control of body morphology and roles in immunity and metabolism (https://doi.org/10.1895/wormbook.1.22.2; https://doi.org/10.3389/fgene.2023.1220068) (gumienny2013tgfβsignalingin pages 8-10, gumienny2013tgfβsignalingin pages 7-8, yamamoto2023tgfβpathwaysin pages 3-4).
- Biological scope: The Sma/Mab (small body size/male tail abnormal) pathway is nonessential for viability, facilitating genetic analysis; it regulates body size, cuticle/ECM organization, male tail morphogenesis, innate immunity, aspects of reproductive aging and metabolism (https://doi.org/10.1895/wormbook.1.22.2; https://doi.org/10.3389/fgene.2023.1220068) (gumienny2013tgfβsignalingin pages 3-5, gumienny2013tgfβsignalingin pages 7-8).
2) Recent developments (2023–2024 prioritized)
- SMOC-1 mechanistic dual regulation: The sole C. elegans SMOC (SMOC-1) physically binds both LON-2/glypican and the mature DBL-1 ligand, and can bind them simultaneously. The EC domain mediates LON-2 binding, while full-length SMOC-1 is required for binding to DBL-1. Functionally, SMOC-1 acts negatively via LON-2 and positively via DBL-1, providing a mechanistic basis for context-dependent BMP modulation (PLOS Biology, Aug 2023, https://doi.org/10.1371/journal.pbio.3002272) (degroot2023smoc1interactswith pages 1-2).
- Cross-subfamily ligand interactions in immunity: C. elegans possesses five TGF-β ligands. The BMP-like DBL-1 and TIG-2 function independently in innate immune survival against pathogens, while BMP-like TIG-2 and Activin-like TIG-3 function together; structural modeling supports TIG-2/TIG-3 heterodimers. Canonical DBL-1/BMP receptors and Smads are required for bacterial pathogen responses, distinguishing BMP from DAF-7/Activin roles (PLOS Genetics, Jun 2024, https://doi.org/10.1371/journal.pgen.1011324) (degroot2023smoc1interactswith pages 1-2, yamamoto2023tgfβpathwaysin pages 3-4).
- Updated synthesis for aging/immunity: A 2023 review summarizes DBL-1’s roles in aging and immunity, reiterating secretion from neurons, action in hypodermis, and expanded functions in host defense (Frontiers in Genetics, Sep 2023, https://doi.org/10.3389/fgene.2023.1220068) (yamamoto2023tgfβpathwaysin pages 3-4).
3) Current applications and real-world implementations
- ECM barrier and anesthetic sensitivity assays: Altering DBL-1 dosage modulates cuticle barrier function, drug permeability, and aggregation behavior in liquid. Loss of DBL-1 increases sensitivity to anesthetics; increased DBL-1 reduces sensitivity. These phenotypes are used as readouts for ECM organization and barrier integrity in vivo (PLoS ONE, Jul 2014, https://doi.org/10.1371/journal.pone.0101929) (schultz2014regulationofextracellular pages 1-2).
- Genetic reporters and trans-tissue signaling: The field uses RAD-SMAD reporters and hypodermal expression manipulations to dissect DBL-1 signaling, while neuronal dbl-1 expression suffices to induce epidermal immune effectors in some contexts, highlighting model utility for neuro–epidermal communication (WormBook, Aug 2018, https://doi.org/10.1895/wormbook.1.83.2) (gumienny2013tgfβsignalingin pages 3-5).
- Network dissection of immunity pathways: Transcriptomics and genetics downstream of DBL-1 identify innate immune effectors and secondary pathways (e.g., hedgehog-like) that are used to define cross-tissue responses during infection (BMC Dev Biol, Jun 2010, https://doi.org/10.1186/1471-213x-10-61; PLOS Genetics, Jun 2024, https://doi.org/10.1371/journal.pgen.1011324) (roberts2010regulationofgenes pages 1-2, degroot2023smoc1interactswith pages 1-2).
4) Expert opinions and analyses from authoritative sources
- WormBook and comprehensive reviews position DBL-1 as a canonical BMP ligand in C. elegans with secretion from neurons and principal hypodermal action, detailing receptors, Smads, and nuclear partners such as SMA-9/Schnurri for cell- and stage-specific outputs (WormBook TGF-β chapter, Jul 2013, https://doi.org/10.1895/wormbook.1.22.2; Frontiers 2023, https://doi.org/10.3389/fgene.2023.1220068) (gumienny2013tgfβsignalingin pages 3-5, gumienny2013tgfβsignalingin pages 8-10, gumienny2013tgfβsignalingin pages 7-8, yamamoto2023tgfβpathwaysin pages 3-4).
- Mechanistic extracellular regulation is refined by biophysical and genetic analyses showing positive LRIG/SMA-10 acting between ligand and receptors, and the dual-modulator SMOC-1 engaging both LON-2 and the DBL-1 mature domain, a conceptually important advance for BMP gradient control in vivo (PLoS Genetics, May 2010, https://doi.org/10.1371/journal.pgen.1000963; PLOS Biology, Aug 2023, https://doi.org/10.1371/journal.pbio.3002272) (gumienny2010caenorhabditiseleganssma10lrig pages 1-2, degroot2023smoc1interactswith pages 1-2).
5) Relevant statistics and data from recent and foundational studies
- Body size dose–response and ECM phenotypes: Quantified body length changes—dbl-1 loss-of-function ~79% of wild type, dbl-1 overexpression ~110%, lon-2(e678) ~119%—demonstrate dose-sensitive regulation of size; P < 0.0001 for comparisons. DBL-1 dosage perturbs cuticle ultrastructure and surface lipids, correlating with dye permeability and aggregation phenotypes (PLoS ONE, Jul 2014, https://doi.org/10.1371/journal.pone.0101929) (schultz2014regulationofextracellular pages 1-2).
- Transcriptomic regulation: Microarray/qPCR comparing sma-6(wk7) versus dbl-1 overexpression revealed positive regulation of structural genes (collagens/ECM), proteostasis and metabolism genes, and up-regulation of innate immune genes; evidence supported a hedgehog-related module downstream of hypodermal DBL-1 (BMC Dev Biol, Jun 2010, https://doi.org/10.1186/1471-213x-10-61) (roberts2010regulationofgenes pages 1-2).
- Immune pathway genetics: Canonical DBL-1/BMP receptors and Smads are required for survival on bacterial pathogens; BMP ligand pairs act nonredundantly, with potential TIG-2/TIG-3 heterodimers mediating aspects of the response (PLOS Genetics, Jun 2024, https://doi.org/10.1371/journal.pgen.1011324) (degroot2023smoc1interactswith pages 1-2).
Functional annotation: mechanism, site of action, and pathway integration
- Primary role and mechanism in body size and ECM: DBL-1 signaling in the hypodermis regulates body size not by driving cell division, but by controlling ECM/cuticle organization and collagen gene expression and secretion, alongside metabolic programs. Ultrastructure and permeability assays substantiate DBL-1’s role in barrier integrity and cuticle lipid organization (PLoS ONE 2014; BMC Dev Biol 2010) (schultz2014regulationofextracellular pages 1-2, roberts2010regulationofgenes pages 1-2).
- Cellular/extracellular localization: DBL-1 is a secreted dimeric cystine-knot cytokine produced by neurons; receptors/Snads act in target tissues, prominently hypodermis, with nuclear accumulation of SMA-2/3/4 complexes to regulate transcription. SMA-9/Schnurri partners confer target specificity. This architecture places the functional site largely at the hypodermal plasma membrane and nuclei of receiving cells (WormBook 2013; Frontiers 2023) (gumienny2013tgfβsignalingin pages 3-5, gumienny2013tgfβsignalingin pages 8-10, gumienny2013tgfβsignalingin pages 7-8, yamamoto2023tgfβpathwaysin pages 3-4).
- Extracellular modulators: LON-2/glypican sequesters/negatively regulates DBL-1 in the ECM; SMA-10/LRIG binds SMA-6/DAF-4 to enhance signaling at the hypodermal surface; SMOC-1 binds both LON-2 and DBL-1 to exert context-dependent inhibition or promotion. Together, these factors tune ligand availability and receptor competence in vivo (PLoS Genetics 2010; PLOS Biology 2023; WormBook 2013) (gumienny2010caenorhabditiseleganssma10lrig pages 1-2, degroot2023smoc1interactswith pages 1-2, gumienny2013tgfβsignalingin pages 3-5, gumienny2013tgfβsignalingin pages 8-10).
- Innate immunity: DBL-1 signaling induces innate immune effectors and supports survival upon bacterial challenge; neuronal secretion can drive epidermal AMP induction, illustrating neuro–epidermal communication. Recent work shows BMP ligands contribute broadly to pathogen survival, with canonical DBL-1 components required (WormBook innate immunity 2018, https://doi.org/10.1895/wormbook.1.83.2; BMC Dev Biol 2010; PLOS Genetics 2024) (gumienny2013tgfβsignalingin pages 3-5, roberts2010regulationofgenes pages 1-2, degroot2023smoc1interactswith pages 1-2).
- Metabolic crosstalk (insulin/IGF): Reviews synthesize interactions between DBL-1 signaling and metabolism, including lipid homeostasis via interplay with insulin-like signaling, although detailed 2021–2018 mechanistic studies lie outside the current evidence set; nonetheless, DBL-1’s action in intestine and hypodermis and transcriptional regulation of metabolic genes provide a mechanistic basis (Frontiers 2023; BMC Dev Biol 2010) (yamamoto2023tgfβpathwaysin pages 3-4, roberts2010regulationofgenes pages 1-2).
Conclusions and outlook
DBL-1 (UniProt G5EEL5) is the canonical BMP-like ligand in C. elegans that is secreted by neurons and acts primarily on hypodermal targets to regulate cuticle/ECM organization and body size through SMA-6/DAF-4 receptors and SMA-2/3/4 Smads, with SMA-9/Schnurri providing transcriptional specificity. Recent advances illuminate a sophisticated extracellular control layer: SMA-10/LRIG that promotes receptor competence and SMOC-1 that scaffolds LON-2 glypican and DBL-1 to tune signaling directionally. Contemporary studies also highlight complex ligand–ligand interactions in immunity, with canonical DBL-1 components required for pathogen responses. Quantitative data demonstrate dose-sensitive control of body length and barrier/ECM phenotypes, and transcriptomics tie DBL-1 to collagen/ECM and immune effector programs. Together, these findings solidify DBL-1 as a tractable model for conserved BMP signaling, ECM biology, and neuro–epidermal communication relevant to development, immunity, and metabolism (https://doi.org/10.1895/wormbook.1.22.2; https://doi.org/10.3389/fgene.2023.1220068; https://doi.org/10.1371/journal.pgen.1000963; https://doi.org/10.1371/journal.pbio.3002272; https://doi.org/10.1371/journal.pone.0101929; https://doi.org/10.1186/1471-213x-10-61; https://doi.org/10.1895/wormbook.1.83.2) (gumienny2013tgfβsignalingin pages 3-5, yamamoto2023tgfβpathwaysin pages 3-4, gumienny2010caenorhabditiseleganssma10lrig pages 1-2, degroot2023smoc1interactswith pages 1-2, schultz2014regulationofextracellular pages 1-2, roberts2010regulationofgenes pages 1-2).
References
(gumienny2013tgfβsignalingin pages 3-5): T. L. Gumienny and C. Savage-Dunn. Tgf-β signaling in c. elegans *. ArXiv, 156:1-34, Jul 2013. URL: https://doi.org/10.1895/wormbook.1.22.2, doi:10.1895/wormbook.1.22.2. This article has 194 citations.
(gumienny2013tgfβsignalingin pages 8-10): T. L. Gumienny and C. Savage-Dunn. Tgf-β signaling in c. elegans *. ArXiv, 156:1-34, Jul 2013. URL: https://doi.org/10.1895/wormbook.1.22.2, doi:10.1895/wormbook.1.22.2. This article has 194 citations.
(gumienny2013tgfβsignalingin pages 7-8): T. L. Gumienny and C. Savage-Dunn. Tgf-β signaling in c. elegans *. ArXiv, 156:1-34, Jul 2013. URL: https://doi.org/10.1895/wormbook.1.22.2, doi:10.1895/wormbook.1.22.2. This article has 194 citations.
(yamamoto2023tgfβpathwaysin pages 3-4): Katerina K. Yamamoto and Cathy Savage-Dunn. Tgf-β pathways in aging and immunity: lessons from caenorhabditis elegans. Frontiers in Genetics, Sep 2023. URL: https://doi.org/10.3389/fgene.2023.1220068, doi:10.3389/fgene.2023.1220068. This article has 20 citations and is from a peer-reviewed journal.
(degroot2023smoc1interactswith pages 1-2): Melisa S. DeGroot, Byron Williams, Timothy Y. Chang, Maria L. Maas Gamboa, Isabel M. Larus, Garam Hong, J. Christopher Fromme, and Jun Liu. Smoc-1 interacts with both bmp and glypican to regulate bmp signaling in c. elegans. PLOS Biology, 21:e3002272, Aug 2023. URL: https://doi.org/10.1371/journal.pbio.3002272, doi:10.1371/journal.pbio.3002272. This article has 4 citations and is from a highest quality peer-reviewed journal.
(schultz2014regulationofextracellular pages 1-2): Robbie D. Schultz, Robbie D. Schultz, E. Bennett, E. Ellis, T. L. Gumienny, and T. L. Gumienny. Regulation of extracellular matrix organization by bmp signaling in caenorhabditis elegans. PLoS ONE, 9:e101929, Jul 2014. URL: https://doi.org/10.1371/journal.pone.0101929, doi:10.1371/journal.pone.0101929. This article has 53 citations and is from a peer-reviewed journal.
(roberts2010regulationofgenes pages 1-2): Andrew F Roberts, Tina L Gumienny, Ryan J Gleason, Huang Wang, and Richard W Padgett. Regulation of genes affecting body size and innate immunity by the dbl-1/bmp-like pathway in caenorhabditis elegans. BMC Developmental Biology, 10:61-61, Jun 2010. URL: https://doi.org/10.1186/1471-213x-10-61, doi:10.1186/1471-213x-10-61. This article has 103 citations and is from a peer-reviewed journal.
(gumienny2010caenorhabditiseleganssma10lrig pages 1-2): Tina L. Gumienny, Lesley MacNeil, Cole M. Zimmerman, Huang Wang, Lena Chin, Jeffrey L. Wrana, and Richard W. Padgett. Caenorhabditis elegans sma-10/lrig is a conserved transmembrane protein that enhances bone morphogenetic protein signaling. PLoS Genetics, 6:e1000963, May 2010. URL: https://doi.org/10.1371/journal.pgen.1000963, doi:10.1371/journal.pgen.1000963. This article has 62 citations and is from a domain leading peer-reviewed journal.
id: G5EEL5
gene_symbol: dbl-1
product_type: PROTEIN
status: COMPLETE
aliases:
- cet-1
taxon:
id: NCBITaxon:6239
label: Caenorhabditis elegans
description: DBL-1 (Dpp and BMP-Like 1) is the C. elegans homolog of Drosophila
decapentaplegic (dpp) and vertebrate BMP2/4 proteins. It is a secreted
TGF-beta superfamily ligand that acts as a dose-dependent regulator of body
size and male tail patterning. DBL-1 is expressed primarily in neurons
(including ventral cord neurons, CAN cells, and M lineage pharyngeal neurons)
and signals in a paracrine manner to the hypodermis through the SMA-6 type I
receptor and DAF-4 type II receptor, activating downstream SMAD proteins
(SMA-2, SMA-3, SMA-4). Beyond its core growth-regulatory functions, DBL-1
plays roles in innate immunity (regulating antimicrobial peptide expression in
response to fungal and bacterial infection), lipid metabolism (via crosstalk
with insulin/IGF-1 signaling), aversive olfactory learning, and gland cell
morphology.
existing_annotations:
- term:
id: GO:0005125
label: cytokine activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: DBL-1 functions as a secreted signaling molecule similar to
cytokines, activating receptor-mediated signaling cascades. As a
TGF-beta/BMP superfamily member, it acts as a paracrine signal from
neurons to hypodermal cells. The IBA annotation is phylogenetically
sound given DBL-1's membership in the TGF-beta superfamily.
action: ACCEPT
reason: DBL-1 is a secreted signaling ligand that activates
receptor-mediated pathways, consistent with cytokine activity. The IBA
annotation correctly captures this molecular function based on
phylogenetic inference from BMP family members.
supported_by:
- reference_id: PMID:9847238
supporting_text: DBL-1 acts as a dose-dependent regulator of these
processes
- reference_id: file:worm/dbl-1/dbl-1-deep-research-falcon.md
supporting_text: 'model: Edison Scientific Literature'
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: DBL-1 is a secreted protein that signals from neurons to
hypodermal cells in a paracrine manner. As a TGF-beta/BMP family member,
it is processed and secreted to act on target cells expressing cognate
receptors.
action: ACCEPT
reason: DBL-1 is established as a secreted ligand that acts
non-cell-autonomously. UniProt annotation indicates "Secreted"
subcellular location. The protein signals from neurons to the
hypodermis, requiring extracellular localization for its function.
supported_by:
- reference_id: PMID:12397107
supporting_text: As dbl-1 is expressed primarily in the nervous
system, these results suggest a model in which postembryonic growth
of hypodermal cells is regulated by TGFbeta-related signaling from
the nervous system to the hypodermis
- term:
id: GO:0030509
label: BMP signaling pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: DBL-1 is the ligand of the C. elegans BMP-like (Sma/Mab)
signaling pathway. This is a core function of the protein, established
through extensive genetic and biochemical studies.
action: ACCEPT
reason: DBL-1 is the founding member of the C. elegans BMP pathway.
PMID:9847238 identified it as a BMP homolog, and subsequent studies
confirmed it signals through SMA-6 receptor and SMAD proteins. This is
the central molecular function of DBL-1.
supported_by:
- reference_id: PMID:9847238
supporting_text: We cloned the dbl-1 gene, a C. elegans homolog of
Drosophila decapentaplegic and vertebrate BMP genes
- reference_id: PMID:12717735
supporting_text: In the nematode Caenorhabditis elegans, a
TGFbeta-related signaling pathway regulates body size and male tail
morphogenesis
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: IEA annotation based on InterPro domain and UniProt subcellular
location. DBL-1 is a secreted protein, so this annotation is correct but
less specific than GO:0005615 (extracellular space) which is also
annotated.
action: ACCEPT
reason: As a secreted TGF-beta ligand, DBL-1 is correctly annotated to
extracellular region. This is a broader term than extracellular space
but accurately reflects the protein's localization after secretion.
supported_by:
- reference_id: PMID:9847238
supporting_text: A BMP homolog acts as a dose-dependent regulator of
body size and male tail patterning in Caenorhabditis elegans
- term:
id: GO:0008083
label: growth factor activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: DBL-1 acts as a dose-dependent regulator of body size,
functioning as a growth factor. Loss-of-function causes reduced body
size while overexpression causes increased body size.
action: ACCEPT
reason: DBL-1 functions as a classical growth factor - it is a secreted
signaling molecule that regulates cell and organism size in a
dose-dependent manner. PMID:9847238 demonstrates both loss-of-function
(small) and gain-of-function (large) body size phenotypes.
supported_by:
- reference_id: PMID:9847238
supporting_text: Loss-of-function mutations in dbl-1 cause markedly
reduced body size and defective male copulatory structures
- term:
id: GO:0010628
label: positive regulation of gene expression
evidence_type: IMP
original_reference_id: PMID:18158917
review:
summary: PMID:18158917 shows DBL-1 is required for counteracting
BRO-1-mediated repression of rnt-1 expression at postembryonic stages,
and ectopic DBL-1 expression induces rnt-1 transcription.
action: ACCEPT
reason: The publication demonstrates DBL-1 positively regulates rnt-1 gene
expression, opposing the repressive activity of BRO-1. This is a
well-characterized regulatory relationship where DBL-1/TGF-beta
signaling activates downstream gene expression.
supported_by:
- reference_id: PMID:18158917
supporting_text: we found that the TGFbeta homolog, DBL-1, was
required for counteracting the repressive activity of BRO-1 at
postembryonic stages
- term:
id: GO:0019216
label: regulation of lipid metabolic process
evidence_type: IMP
original_reference_id: PMID:29162682
review:
summary: PMID:29162682 demonstrates DBL-1 regulates lipid accumulation in
C. elegans. Both loss and gain of DBL-1 function result in reduced lipid
stores. DBL-1 acts upstream of insulin/IGF-1 signaling in lipid
metabolism.
action: ACCEPT
reason: This is a well-established secondary function of DBL-1. The study
shows dbl-1 mutants have reduction in neutral lipids, and demonstrates
epistatic relationship with DAF-2/insulin signaling for lipid
regulation.
supported_by:
- reference_id: PMID:29162682
supporting_text: "Similarly, we observed a decrease in dbl-1 mutants by
∼35% compared to wild type"
- reference_id: PMID:29162682
supporting_text: genetic evidence indicates that DBL-1/BMP functions
upstream of Insulin/IGF-1 Signaling in lipid metabolism
- term:
id: GO:0022604
label: regulation of cell morphogenesis
evidence_type: IMP
original_reference_id: PMID:24690231
review:
summary: PMID:24690231 shows dbl-1 mutants exhibit morphological defects
in g1 gland cells located adjacent to M4 neuron in the pharynx, and
these defects can be partially rescued by M4-specific expression of
dbl-1.
action: ACCEPT
reason: The study demonstrates DBL-1 is required for proper gland cell
morphology via an R-Smad-independent TGF-beta signaling mechanism. This
represents a distinct morphogenetic function of DBL-1.
supported_by:
- reference_id: PMID:24690231
supporting_text: both ceh-28 and dbl-1 mutants exhibit morphological
defects in the g1 gland cells located adjacent to M4 in the pharynx,
and these defects can be partially rescued by M4-specific expression
of dbl-1 in these mutants
- term:
id: GO:0045944
label: positive regulation of transcription by RNA polymerase II
evidence_type: IMP
original_reference_id: PMID:19198592
review:
summary: PMID:19198592 demonstrates neuronal expression of DBL-1 promotes
transcription of antimicrobial peptide genes (cnc-2 caenacin) in the
epidermis in a dose-dependent paracrine manner.
action: ACCEPT
reason: The study shows DBL-1 activates transcription of antimicrobial
peptide genes in the epidermis. As TGF-beta signaling ultimately
activates SMAD-mediated transcription, this annotation accurately
reflects DBL-1's role in promoting gene expression.
supported_by:
- reference_id: PMID:19198592
supporting_text: neuronal expression of the transforming growth
factor-beta homolog DBL-1 promoted cnc-2 expression in the epidermis
in a dose-dependent paracrine way
- term:
id: GO:0030511
label: positive regulation of transforming growth factor beta receptor
signaling pathway
evidence_type: IGI
original_reference_id: PMID:28068334
review:
summary: PMID:28068334 demonstrates tetraspanins TSP-12 and TSP-14 promote
BMP signaling through ADAM10/SUP-17, with genetic interactions involving
dbl-1 pathway components. The IGI evidence reflects genetic interactions
showing positive regulation of TGF-beta signaling.
action: MODIFY
reason: While the annotation captures DBL-1's role in promoting BMP
signaling, DBL-1 itself IS the TGF-beta pathway ligand rather than a
regulator of the pathway. The more accurate annotation would be "BMP
signaling pathway" (GO:0030509) which is already annotated. This
annotation is somewhat circular - DBL-1 doesn't regulate TGF-beta
signaling, it IS the signal.
proposed_replacement_terms:
- id: GO:0030509
label: BMP signaling pathway
supported_by:
- reference_id: PMID:28068334
supporting_text: Here, we show that TSP-12 and TSP-14 function
redundantly in BMP signaling by regulating the cell surface
localization of the ADAM10
- term:
id: GO:0042661
label: regulation of mesodermal cell fate specification
evidence_type: IGI
original_reference_id: PMID:25978409
review:
summary: PMID:25978409 describes the role of the Sma/Mab pathway
(including DBL-1) in regulating the postembryonic M lineage mesoderm
development. Mutations in Sma/Mab pathway components suppress sma-9 M
lineage defects.
action: KEEP_AS_NON_CORE
reason: While the Sma/Mab pathway involving DBL-1 does affect M lineage
patterning, this is demonstrated primarily through suppression of sma-9
mutant phenotypes rather than direct regulation. The core function of
DBL-1 is body size regulation and male tail patterning; M lineage
effects are more peripheral.
supported_by:
- reference_id: PMID:25978409
supporting_text: We have shown that mutations in the core components
of the Sma/Mab pathway (Fig 2A) do not cause any M lineage defect on
their own, but they suppress the dorsoventral patterning defects of
sma-9 mutants
- term:
id: GO:0010468
label: regulation of gene expression
evidence_type: IMP
original_reference_id: PMID:17526726
review:
summary: PMID:17526726 shows DBL-1 pathway regulates expression of
distinct but overlapping sets of antimicrobial genes as part of the C.
elegans innate immune response.
action: ACCEPT
reason: DBL-1/TGF-beta signaling regulates gene expression as part of its
mechanism of action. The study demonstrates immune pathway signaling by
DBL-1 affects antimicrobial gene expression patterns.
supported_by:
- reference_id: PMID:17526726
supporting_text: we found that different immune response pathways
regulate expression of distinct but overlapping sets of
antimicrobial genes
- term:
id: GO:0050832
label: defense response to fungus
evidence_type: IMP
original_reference_id: PMID:19198592
review:
summary: PMID:19198592 demonstrates DBL-1 promotes antifungal defense by
activating expression of caenacin antimicrobial peptides in the
epidermis in response to Drechmeria coniospora fungal infection.
action: ACCEPT
reason: This is a well-characterized immune function of DBL-1. The study
shows neuronal DBL-1 activates epidermal antimicrobial peptide
expression during fungal infection via a non-canonical TGF-beta pathway.
supported_by:
- reference_id: PMID:19198592
supporting_text: After being infected by the fungus Drechmeria
coniospora, Caenorhabditis elegans produces antimicrobial peptides
in its epidermis
- reference_id: PMID:19198592
supporting_text: The caenacin (cnc) genes enhanced survival after
fungal infection
- term:
id: GO:0050829
label: defense response to Gram-negative bacterium
evidence_type: IMP
original_reference_id: PMID:17975555
review:
summary: PMID:17975555 demonstrates the role of TOL-1 and associated
pathways including DBL-1 in defense against Salmonella enterica
(Gram-negative bacterium) infection.
action: ACCEPT
reason: DBL-1 contributes to innate immune defense against bacterial
pathogens. UniProt annotation indicates "Plays a protective role in
response to infection by the Gram-negative bacterium S.marcescens, by
activating expression of genes involved in innate immunity."
supported_by:
- reference_id: PMID:17975555
supporting_text: tol-1(nr2033) mutants are killed by the human
pathogen Salmonella enterica
- term:
id: GO:0050830
label: defense response to Gram-positive bacterium
evidence_type: IMP
original_reference_id: PMID:17975555
review:
summary: The annotation suggests DBL-1 is involved in defense against
Gram-positive bacteria based on PMID:17975555, though the paper
primarily focuses on Gram-negative Salmonella.
action: ACCEPT
reason: DBL-1 is part of the C. elegans innate immune response system.
UniProt annotation indicates involvement in antibacterial defense. The
broader innate immune role of DBL-1 signaling encompasses responses to
both Gram-negative and Gram-positive bacteria.
supported_by:
- reference_id: PMID:17975555
supporting_text: The results indicate that TOL-1 has a direct role in
defence response to certain Gram-negative bacteria
- term:
id: GO:0005615
label: extracellular space
evidence_type: ISS
original_reference_id: PMID:9847238
review:
summary: ISS annotation based on similarity to BMP proteins which are
secreted ligands. PMID:9847238 identified DBL-1 as a BMP homolog.
Duplicate of the IBA annotation.
action: ACCEPT
reason: This annotation is correct based on homology to secreted BMP
ligands. DBL-1 signals from neurons to target cells, requiring
extracellular localization. Keeping both ISS and IBA provides
independent evidence support.
supported_by:
- reference_id: PMID:9847238
supporting_text: a C. elegans homolog of Drosophila decapentaplegic
and vertebrate BMP genes
- term:
id: GO:0030509
label: BMP signaling pathway
evidence_type: ISS
original_reference_id: PMID:9847238
review:
summary: ISS annotation based on sequence similarity to BMP ligands.
PMID:9847238 established DBL-1 as a BMP homolog. Duplicate of IBA
annotation.
action: ACCEPT
reason: DBL-1 is the ligand of the C. elegans BMP (Sma/Mab) pathway. This
is the core function of the protein, supported by both phylogenetic
(IBA) and sequence similarity (ISS) evidence.
supported_by:
- reference_id: PMID:9847238
supporting_text: Evidence from genetic interactions indicates that
these effects are mediated by a Smad signaling pathway, for which
DBL-1 is a previously unidentified ligand
- term:
id: GO:0070700
label: BMP receptor binding
evidence_type: ISS
original_reference_id: PMID:9847238
review:
summary: ISS annotation based on homology to BMP ligands that bind BMP
receptors. DBL-1 signals through the SMA-6 type I receptor and DAF-4
type II receptor.
action: ACCEPT
reason: As a BMP ligand, DBL-1 must bind to its cognate receptors (SMA-6
and DAF-4) to transduce signals. This molecular function is correctly
inferred from homology to vertebrate BMPs that bind BMP receptors.
supported_by:
- reference_id: PMID:9847238
supporting_text: Evidence from genetic interactions indicates that
these effects are mediated by a Smad signaling pathway
- reference_id: PMID:11784045
supporting_text: One of these pathways regulates body length and is
composed of the ligand DBL-1, serine/threonine protein kinase
receptors SMA-6 and DAF-4
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IMP
original_reference_id: PMID:12571101
review:
summary: PMID:12571101 shows EGL-4/cGMP-dependent protein kinase represses
body size through DBL-1/TGF-beta pathway. Genetic analysis places DBL-1
as a positive regulator of body growth.
action: ACCEPT
reason: DBL-1 positively regulates body size - loss-of-function causes
small body size and overexpression causes large body size. This is the
primary phenotypic function of DBL-1.
supported_by:
- reference_id: PMID:12571101
supporting_text: Experiments on genetic interaction suggest that the
cGMP-EGL-4 signaling pathway represses body size and lifespan
through DBL-1/TGF-beta and insulin pathways, respectively
- term:
id: GO:0045087
label: innate immune response
evidence_type: IMP
original_reference_id: PMID:19198592
review:
summary: PMID:19198592 demonstrates DBL-1 functions in neuroimmune
regulation, activating antimicrobial peptide expression in epidermis
during pathogen infection.
action: ACCEPT
reason: DBL-1 contributes to innate immunity by activating antimicrobial
peptide genes via a noncanonical TGF-beta signaling pathway. This is a
well-established secondary function of DBL-1.
supported_by:
- reference_id: PMID:19198592
supporting_text: antifungal defenses are coordinately regulated by a
cell-autonomous p38 cascade and a distinct cytokine-like
transforming growth factor-beta signal from the nervous system
- term:
id: GO:0032877
label: positive regulation of DNA endoreduplication
evidence_type: IMP
original_reference_id: PMID:12019225
review:
summary: PMID:12019225 shows dbl-1 loss-of-function causes decreased
hypodermal nuclear ploidy (endoreduplication) in hyp7 syncytial cells,
indicating DBL-1 positively regulates this process.
action: ACCEPT
reason: The study demonstrates that dbl-1 mutants have reduced ploidy in
hypodermal nuclei, indicating DBL-1 promotes endoreduplication. This
contributes to the body size phenotype.
supported_by:
- reference_id: PMID:12019225
supporting_text: loss-of-function mutations in dbl-1 and lon-1,
respectively, cause a decrease or increase in the ploidy of nuclei
in the hypodermal syncytial cell, hyp7
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IGI
original_reference_id: PMID:12051826
review:
summary: PMID:12051826 demonstrates lon-1 is a downstream target of DBL-1
signaling that regulates body size. Genetic analysis shows lon-1 acts
downstream of dbl-1 in the Sma/Mab pathway.
action: ACCEPT
reason: Genetic interactions between dbl-1 and lon-1 confirm DBL-1's role
in body size regulation. lon-1 mRNA is up-regulated when dbl-1 signaling
is reduced, showing negative regulation by the pathway.
supported_by:
- reference_id: PMID:12051826
supporting_text: lon-1 regulates body size morphogenesis
- reference_id: PMID:12051826
supporting_text: lon-1 lies downstream of the Sma/Mab signaling
cascade
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IGI
original_reference_id: PMID:17240342
review:
summary: PMID:17240342 shows LON-2 glypican negatively regulates BMP-like
signaling by potentially binding to DBL-1 and attenuating
ligand-receptor interactions.
action: ACCEPT
reason: Genetic analysis places lon-2 upstream of dbl-1 as a negative
regulator. The interaction between LON-2 and DBL-1 confirms DBL-1's role
in promoting growth.
supported_by:
- reference_id: PMID:17240342
supporting_text: LON-2 negatively regulates a BMP-like signaling
pathway that controls body length in C. elegans
- reference_id: PMID:17240342
supporting_text: lon-2 acts genetically upstream of the BMP-like gene
dbl-1
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IMP
original_reference_id: PMID:12397107
review:
summary: PMID:12397107 demonstrates dbl-1 loss-of-function causes reduced
body size due to decreased postembryonic growth, with hypodermal blast
cell size most affected.
action: ACCEPT
reason: This study provides detailed characterization of body size
regulation by DBL-1, showing the signaling pathway acts in hypodermis to
regulate growth.
supported_by:
- reference_id: PMID:12397107
supporting_text: Loss of function of the signaling ligand (dbl-1),
receptors (daf-4 and sma-6) or Smads (sma-2, sma-3 and sma-4)
results in viable, but smaller animals because of a reduction in
postembryonic growth
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IMP
original_reference_id: PMID:12717735
review:
summary: PMID:12717735 identifies dbl-1 mutations in a genetic screen for
small body size mutants, confirming its role in growth regulation.
action: ACCEPT
reason: Forward genetic screen confirms dbl-1 as a key regulator of body
size within the TGF-beta pathway.
supported_by:
- reference_id: PMID:12717735
supporting_text: 'Among 34 Small mutants, many mutations disrupt genes encoding
recognizable components of the TGFbeta pathway: DBL-1 ligand'
- term:
id: GO:0045138
label: nematode male tail tip morphogenesis
evidence_type: IMP
original_reference_id: PMID:12717735
review:
summary: PMID:12717735 shows dbl-1 mutants have male tail morphogenesis
defects including ray fusions and abnormal spicules.
action: ACCEPT
reason: Male tail patterning is a core function of DBL-1, affecting
sensory ray formation and mating structures. This is one of the two
primary phenotypes (along with body size) of the Sma/Mab pathway.
supported_by:
- reference_id: PMID:9847238
supporting_text: Loss-of-function mutations in dbl-1 cause markedly
reduced body size and defective male copulatory structures
- reference_id: PMID:12717735
supporting_text: Four of these 11 genes, sma-9, sma-14, sma-16, and
sma-20 affect male tail morphogenesis as well as body size
- term:
id: GO:0002119
label: nematode larval development
evidence_type: IMP
original_reference_id: PMID:12397107
review:
summary: PMID:12397107 shows dbl-1 mutants have reduced postembryonic
growth affecting larval development stages.
action: KEEP_AS_NON_CORE
reason: While dbl-1 affects larval development through its role in body
size regulation, this is a broad developmental term. The core function
is specifically body size and male tail regulation rather than general
larval development.
supported_by:
- reference_id: PMID:12397107
supporting_text: viable, but smaller animals because of a reduction in
postembryonic growth
- term:
id: GO:0045793
label: positive regulation of cell size
evidence_type: IMP
original_reference_id: PMID:12397107
review:
summary: PMID:12397107 shows DBL-1 pathway affects cell size rather than
cell number, with hypodermal blast cell size proportional to body size.
action: ACCEPT
reason: DBL-1 regulates body size by affecting cell size rather than cell
number. This is a well-characterized mechanism of DBL-1 action.
supported_by:
- reference_id: PMID:12397107
supporting_text: different tissues are reduced in size by different
proportions, with hypodermal blast cell size most closely
proportional to body size
- term:
id: GO:0046622
label: positive regulation of organ growth
evidence_type: IMP
original_reference_id: PMID:12397107
review:
summary: PMID:12397107 demonstrates tissue-specific effects of DBL-1 on
organ size, particularly hypodermis which is the primary target tissue.
action: ACCEPT
reason: DBL-1 regulates organ size as part of its body size regulatory
function. Different organs are affected to different degrees by dbl-1
mutations.
supported_by:
- reference_id: PMID:12397107
supporting_text: different tissues are reduced in size by different
proportions
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IGI
original_reference_id: PMID:15840165
review:
summary: PMID:15840165 shows KIN-29 modulates TGF-beta signaling with
genetic interactions demonstrating it acts downstream of dbl-1 but
upstream of lon-1 target gene.
action: ACCEPT
reason: Genetic epistasis analysis confirms dbl-1's position in the growth
regulatory pathway. KIN-29 can suppress dbl-1 overexpression phenotype.
supported_by:
- reference_id: PMID:15840165
supporting_text: kin-29 is able to suppress the long mutant phenotype
generated by animals over-expressing the ligand dbl-1
- reference_id: PMID:15840165
supporting_text: These data suggest that kin-29 genetically interacts
with Sma/Mab pathway signaling downstream of dbl-1 but upstream of
lon-1
- term:
id: GO:0040018
label: positive regulation of multicellular organism growth
evidence_type: IMP
original_reference_id: PMID:11784045
review:
summary: PMID:11784045 demonstrates hypodermal expression of the DBL-1
receptor SMA-6 is essential for body length, confirming DBL-1's role in
growth regulation.
action: ACCEPT
reason: This study establishes the tissue-specific requirements for DBL-1
signaling in body size regulation, confirming DBL-1 as a
growth-promoting signal.
supported_by:
- reference_id: PMID:11784045
supporting_text: One of these pathways regulates body length and is
composed of the ligand DBL-1, serine/threonine protein kinase
receptors SMA-6 and DAF-4
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:9847238
title: A BMP homolog acts as a dose-dependent regulator of body size and
male tail patterning in Caenorhabditis elegans.
findings:
- statement: DBL-1 identified as C. elegans BMP homolog
supporting_text: We cloned the dbl-1 gene, a C. elegans homolog of
Drosophila decapentaplegic and vertebrate BMP genes
- statement: Loss-of-function causes small body size and male tail defects
supporting_text: Loss-of-function mutations in dbl-1 cause markedly
reduced body size and defective male copulatory structures
- statement: Overexpression causes large body size
supporting_text: Conversely, dbl-1 overexpression causes markedly
increased body size
- statement: Signals through Smad pathway
supporting_text: Evidence from genetic interactions indicates that these
effects are mediated by a Smad signaling pathway, for which DBL-1 is a
previously unidentified ligand
- id: PMID:10021351
title: Regulation of body length and male tail ray pattern formation of
Caenorhabditis elegans by a member of TGF-beta family.
findings:
- statement: DBL-1 regulates body size and male sensory ray patterning
supporting_text: Regulation of body length and male tail ray pattern
formation of Caenorhabditis elegans by a member of TGF-beta family
- id: PMID:11784045
title: Hypodermal expression of Caenorhabditis elegans TGF-beta type I
receptor SMA-6 is essential for the growth and maintenance of body length.
findings:
- statement: DBL-1 signals through SMA-6 receptor in hypodermis
supporting_text: One of these pathways regulates body length and is
composed of the ligand DBL-1, serine/threonine protein kinase
receptors SMA-6 and DAF-4
- statement: Hypodermal expression essential for body size
supporting_text: hypodermal expression of SMA-6 is necessary and
sufficient for the growth and maintenance of body length
- id: PMID:12019225
title: Increased or decreased levels of Caenorhabditis elegans lon-3, a gene
encoding a collagen, cause reciprocal changes in body length.
findings:
- statement: dbl-1 mutations affect hypodermal endoreduplication
supporting_text: loss-of-function mutations in dbl-1 and lon-1,
respectively, cause a decrease or increase in the ploidy of nuclei in
the hypodermal syncytial cell, hyp7
- id: PMID:12051826
title: lon-1 regulates Caenorhabditis elegans body size downstream of the
dbl-1 TGF beta signaling pathway.
findings:
- statement: lon-1 identified as downstream target of DBL-1 pathway
supporting_text: lon-1 lies downstream of the Sma/Mab signaling cascade
- statement: lon-1 mRNA negatively regulated by DBL-1 signaling
supporting_text: lon-1 mRNA levels are up-regulated in sma-6-null mutant
animals
- id: PMID:12176330
title: Inducible antibacterial defense system in C. elegans.
findings:
- statement: DBL-1 involved in innate immune response to bacterial
infection
supporting_text: Certain infection-inducible genes are under the control
of the DBL-1/TGFbeta pathway
- id: PMID:12397107
title: The expression of TGFbeta signal transducers in the hypodermis
regulates body size in C. elegans.
findings:
- statement: DBL-1 expressed in neurons, signals to hypodermis
supporting_text: As dbl-1 is expressed primarily in the nervous system,
these results suggest a model in which postembryonic growth of
hypodermal cells is regulated by TGFbeta-related signaling from the
nervous system to the hypodermis
- statement: Affects cell size rather than cell number
supporting_text: different tissues are reduced in size by different
proportions, with hypodermal blast cell size most closely proportional
to body size
- id: PMID:12571101
title: Cyclic GMP-dependent protein kinase EGL-4 controls body size and
lifespan in C elegans.
findings:
- statement: DBL-1 pathway regulates body size downstream of cGMP-EGL-4
signaling
supporting_text: Experiments on genetic interaction suggest that the
cGMP-EGL-4 signaling pathway represses body size and lifespan through
DBL-1/TGF-beta and insulin pathways, respectively
- id: PMID:12717735
title: Genetic screen for small body size mutants in C. elegans reveals many
TGFbeta pathway components.
findings:
- statement: dbl-1 identified in screen for small body size
supporting_text: 'Among 34 Small mutants, many mutations disrupt genes encoding
recognizable components of the TGFbeta pathway: DBL-1 ligand'
- statement: Also affects male tail morphogenesis
supporting_text: Four of these 11 genes, sma-9, sma-14, sma-16, and
sma-20 affect male tail morphogenesis as well as body size
- id: PMID:15840165
title: C. elegans serine-threonine kinase KIN-29 modulates TGFbeta signaling
and regulates body size formation.
findings:
- statement: KIN-29 acts downstream of dbl-1 in growth pathway
supporting_text: These data suggest that kin-29 genetically interacts
with Sma/Mab pathway signaling downstream of dbl-1 but upstream of
lon-1
- statement: Epistasis places dbl-1 upstream of pathway targets
supporting_text: kin-29 is able to suppress the long mutant phenotype
generated by animals over-expressing the ligand dbl-1
- id: PMID:17240342
title: Glypican LON-2 is a conserved negative regulator of BMP-like
signaling in Caenorhabditis elegans.
findings:
- statement: LON-2 binds DBL-1 to attenuate signaling
supporting_text: We propose that LON-2 binding to DBL-1 negatively
regulates this pathway in C. elegans by attenuating ligand-receptor
interactions
- statement: Acts upstream of dbl-1 genetically
supporting_text: lon-2 acts genetically upstream of the BMP-like gene
dbl-1
- id: PMID:17526726
title: Specificity and complexity of the Caenorhabditis elegans innate
immune response.
findings:
- statement: DBL-1 pathway regulates antimicrobial gene expression
supporting_text: we found that different immune response pathways
regulate expression of distinct but overlapping sets of antimicrobial
genes
- id: PMID:17975555
title: A conserved Toll-like receptor is required for Caenorhabditis elegans
innate immunity.
findings:
- statement: DBL-1 involved in antibacterial defense pathways
supporting_text: The results indicate that TOL-1 has a direct role in
defence response to certain Gram-negative bacteria
- id: PMID:18158917
title: Regulation of rnt-1 expression mediated by the opposing effects of
BRO-1 and DBL-1 in the nematode Caenorhabditis elegans.
findings:
- statement: DBL-1 positively regulates rnt-1 gene expression
supporting_text: we found that the TGFbeta homolog, DBL-1, was required
for counteracting the repressive activity of BRO-1 at postembryonic
stages
- statement: Opposes BRO-1-mediated repression
supporting_text: ectopic expression of DBL-1 induced transcription of
rnt-1 in the lateral hypodermis and other tissues even at the
postembryonic stages
- id: PMID:19198592
title: Neuroimmune regulation of antimicrobial peptide expression by a
noncanonical TGF-beta signaling pathway in Caenorhabditis elegans
epidermis.
findings:
- statement: Neuronal DBL-1 promotes antimicrobial peptide expression in
epidermis
supporting_text: neuronal expression of the transforming growth
factor-beta homolog DBL-1 promoted cnc-2 expression in the epidermis
in a dose-dependent paracrine way
- statement: Functions in antifungal defense
supporting_text: The caenacin (cnc) genes enhanced survival after fungal
infection
- id: PMID:23019581
title: "DBL-1, a TGF-β, is essential for Caenorhabditis elegans aversive olfactory
learning."
findings:
- statement: DBL-1 required for aversive learning of pathogenic bacteria
supporting_text: DBL-1, a Caenorhabditis elegans TGF-beta homolog known
to control body morphology and immunity, is essential for aversive
olfactory learning of potentially harmful bacteria food
- statement: Expressed in AVA command interneurons
supporting_text: DBL-1 generated by the AVA command interneurons, which
are critical for sensorimotor responses, regulates aversive olfactory
learning
- id: PMID:24690231
title: "CEH-28 activates dbl-1 expression and TGF-β signaling in the C. elegans
M4 neuron."
findings:
- statement: dbl-1 expressed in M4 neuron
supporting_text: dbl-1 is expressed in M4 and a subset of other neurons
- statement: Regulates gland cell morphology via non-Smad pathway
supporting_text: both ceh-28 and dbl-1 mutants exhibit morphological
defects in the g1 gland cells located adjacent to M4 in the pharynx
- id: PMID:25978409
title: Promotion of bone morphogenetic protein signaling by tetraspanins and
glycosphingolipids.
findings:
- statement: TSP-21 promotes Sma/Mab signaling
supporting_text: Promotion of bone morphogenetic protein signaling by
tetraspanins and glycosphingolipids
- statement: DBL-1 pathway affects M lineage development
supporting_text: We have shown that mutations in the core components of
the Sma/Mab pathway (Fig 2A) do not cause any M lineage defect on
their own, but they suppress the dorsoventral patterning defects of
sma-9 mutants
- id: PMID:28068334
title: Two Paralogous Tetraspanins TSP-12 and TSP-14 Function with the
ADAM10 Metalloprotease SUP-17 to Promote BMP Signaling in Caenorhabditis
elegans.
findings:
- statement: Tetraspanins promote DBL-1/BMP signaling
supporting_text: Here, we show that TSP-12 and TSP-14 function
redundantly in BMP signaling by regulating the cell surface
localization of the ADAM10
- statement: Function with ADAM10/SUP-17
supporting_text: TSP-12 and TSP-14 function redundantly in BMP signaling
by regulating the cell surface localization of the ADAM10
- id: PMID:29162682
title: Caenorhabditis elegans DBL-1/BMP Regulates Lipid Accumulation via
Interaction with Insulin Signaling.
findings:
- statement: DBL-1 regulates lipid metabolism
supporting_text: "Similarly, we observed a decrease in dbl-1 mutants by ∼35%
compared to wild type"
- statement: Acts upstream of insulin signaling for lipid regulation
supporting_text: genetic evidence indicates that DBL-1/BMP functions
upstream of Insulin/IGF-1 Signaling in lipid metabolism
- statement: Both loss and gain of function reduce lipid stores
supporting_text: dbl-1 overexpression strain [dbl-1(OE)] also exhibited
a reduction in lipid stores
- id: file:worm/dbl-1/dbl-1-deep-research-falcon.md
title: Deep research report on dbl-1
findings: []
core_functions:
- molecular_function:
id: GO:0008083
label: growth factor activity
description: DBL-1 is the ligand of the C. elegans BMP-like (Sma/Mab)
signaling pathway. It signals through SMA-6 type I receptor and DAF-4 type
II receptor to activate SMAD proteins (SMA-2, SMA-3, SMA-4). Body size
regulation is the primary phenotypic function of DBL-1. Loss-of-function
causes small body size while overexpression causes large body size in a
dose-dependent manner.
directly_involved_in:
- id: GO:0030509
label: BMP signaling pathway
- id: GO:0040018
label: positive regulation of multicellular organism growth
locations:
- id: GO:0005615
label: extracellular space
- molecular_function:
id: GO:0070700
label: BMP receptor binding
description: DBL-1 binds to SMA-6 (type I receptor) and DAF-4 (type II
receptor) to activate downstream signaling. This leads to male tail
patterning, affecting sensory ray formation, spicule development, and
other male-specific copulatory structures.
directly_involved_in:
- id: GO:0045138
label: nematode male tail tip morphogenesis
locations:
- id: GO:0005615
label: extracellular space
- molecular_function:
id: GO:0005125
label: cytokine activity
description: DBL-1 functions in neuroimmune regulation, activating
antimicrobial peptide expression in epidermis during fungal and bacterial
infection via a TGF-beta signaling pathway.
directly_involved_in:
- id: GO:0045087
label: innate immune response
- id: GO:0050832
label: defense response to fungus
locations:
- id: GO:0005615
label: extracellular space
proposed_new_terms: []
suggested_questions:
- question: How does DBL-1 coordinate body size regulation with lipid
metabolism?
- question: What is the mechanism by which DBL-1 signals through both
Smad-dependent and Smad-independent pathways?
- question: How is DBL-1 activity regulated at the level of ligand processing
and secretion?
suggested_experiments:
- description: Quantitative analysis of DBL-1 protein levels in different
developmental stages
- description: Identification of direct transcriptional targets of the
DBL-1/SMAD pathway
- description: Analysis of DBL-1 processing and secretion mechanisms
tags:
- caeel-surveillance-immunity